Purchase Order 75N95021P00314
Award Date
6/29/21
Potential Completion Date
7/27/21
Potential Value
$43K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
AAT Bioquest Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94085, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to AAT Bioquest, Inc., a minority-owned, for-profit, woman-owned small business, and Asian-Pacific American-owned manufacturer of goods. The contract, valued at $161,032.00, is for products or services related to the NIH's mission of accelerating the translation of research to improve human health. The contract does not have a set-aside designation and...
<p>This federal contract award was issued by the National Center for Advancing Translational Sciences, a civilian agency, to AAT Bioquest, Inc. The contract has a ceiling value of $12,570.00 and is a Firm Fixed Price Purchase Order with an ultimate completion date of August 31, 2018. The contract does not have a set-aside designation. Based on the agency and description, this contract is likely related to the agency's research and development efforts in the field of translational sciences.</p>
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed price purchase order to Fisher Scientific Company L.L.C. valued at $24,010.95 to provide multiple formulation-related laboratory tools and equipment. The solicitation requested brand name or equal laboratory items to support the agency's research and development efforts. Performance will take place in Potomac, Maryland over a three-month period...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $12,472 firm fixed price purchase order to Proteinsimple, a division of Bio-Techne Corporation doing business as Bio-Techne, to provide protein analysis services and equipment. The place of performance is in Potomac, Maryland through October 13, 2023. As part of NIH's efforts to advance translational sciences and support, this award will enable Proteinsimple to...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $29,820 firm fixed price purchase order to Medchemexpress LLC to deliver forty-four bioactive compounds for replenishment and expansion of the Mechanism Interrogation PlatE 6.0 screening library. The compounds will support the Center's high-capacity robotic platform used to screen drug combinations and further its chemogenomic screening capabilities. Delivery...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed price purchase order to Revvity Health Sciences, Inc. for the purchase of two reagent kits: the HTRF cAMP Gi Assay kit and the HTRF cAMP Gs Dynamic Assay kit. The total potential value of the award is $243,665.00. These kits will be used by NCATS' Tox21 group to screen a library of 10,000 compounds as part of a cross-partner project...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $32,986.00 firm fixed price purchase order to Life Technologies Corporation, a for-profit manufacturer, for an iBright FL 1500 Imaging System. This non-competitive award was issued under simplified acquisition procedures without a set-aside designation. The solicitation was posted on March 30, 2020 and the award was made on April 8, 2020 for delivery within 6...
This federal contract award is for the purchase of Cisbio Pro-Collagen Type 1 (Human) Kits and Alpha-SMA Assay Kits by the National Center for Advancing Translational Sciences (NCATS), a center within the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services (HHS). The $79,533.50 firm-fixed-price purchase order was awarded to Cisbio US, Inc., a foreign-owned for-profit company, and was not set aside for any small business category. The kits are being procured...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $20,148 firm fixed price delivery order to Beckman Coulter Inc. US Customer Operations Division. This order is for a BIOMEK I7 HYBRID SERVICE AGREEMENT RENEWAL to be performed in Potomac, Maryland from November 2023 through November 2024. The National Center for Advancing Translational Sciences supports clinical and translational science awards and grants to...
<p>This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to AAT Bioquest, Inc. The contract is for the labeling of RNaseB and streptavidin proteins for an NGLY1 project. The total potential value of the contract is $24,800.00. AAT Bioquest, Inc. is a minority-owned, woman-owned small business that manufactures goods. The contract does not have a set-aside designation.</p>